Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin

Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer

(2016) A. Blythe Ryerson et al.   CANCER

β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis

(2015) Satdarshan Pal Monga   GASTROENTEROLOGY

Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model

(2015) Evan Delgado et al.   JOURNAL OF HEPATOLOGY

Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

(2015) B. W. Chen et al.   MOLECULAR CANCER THERAPEUTICS

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

(2015) Kornelius Schulze et al.   NATURE GENETICS

Epidemiology of Hepatocellular Carcinoma

(2015) Kelly J. Lafaro et al.   Surgical Oncology Clinics of North America

mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation?

(2015) Christophe Duvoux et al.   Transplantation Reviews

Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research

(2014) Xin Chen et al.   AMERICAN JOURNAL OF PATHOLOGY

Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice

(2014) Junyan Tao et al.   GASTROENTEROLOGY

FAK Is required for c-Met/β-catenin-driven hepatocarcinogenesis

(2014) Na Shang et al.   HEPATOLOGY

The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease

(2014) Janan T. Eppig et al.   NUCLEIC ACIDS RESEARCH

A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection

(2013) Jean–Charles Nault et al.   GASTROENTEROLOGY

Met as a therapeutic target in HCC: Facts and hopes

(2013) Silvia Giordano et al.   JOURNAL OF HEPATOLOGY

Calpain Induces N-terminal Truncation of β-Catenin in Normal Murine Liver Development

(2012) Abigale Lade et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

L-Asparaginase and Inhibitors of Glutamine Synthetase Disclose Glutamine Addiction of β-Catenin-Mutated Human Hepatocellular Carcinoma Cells

(2011)   CURRENT CANCER DRUG TARGETS

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

(2010) Eunice L. Kwak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model

(2009) C. Armengol et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Targeted therapy for hepatocellular carcinoma

(2009) Hans Christian Spangenberg et al.   Nature Reviews Gastroenterology & Hepatology

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

(2009) R. C. Kane et al.   ONCOLOGIST

Role of Cyclin D1 as a Mediator of c-Met- and  -Catenin-Induced Hepatocarcinogenesis

(2008) M. A. Patil et al.   CANCER RESEARCH

Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene

(2008) Benjamin Cieply et al.   HEPATOLOGY

Novel advancements in the management of hepatocellular carcinoma in 2008

(2008) Josep M. Llovet et al.   JOURNAL OF HEPATOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE